Prostate-specific antigen screening and mortality from prostate cancer
about
Screening for prostate cancerScreening for prostate cancerStatin use and fatal prostate cancer: a matched case-control study.Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time.What explains the differences between centres in the European screening trial? A simulation study.Polymorphisms in the AR and PSA genes as markers of susceptibility and aggressiveness in prostate cancer.
P2860
Prostate-specific antigen screening and mortality from prostate cancer
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Prostate-specific antigen screening and mortality from prostate cancer
@ast
Prostate-specific antigen screening and mortality from prostate cancer
@en
type
label
Prostate-specific antigen screening and mortality from prostate cancer
@ast
Prostate-specific antigen screening and mortality from prostate cancer
@en
prefLabel
Prostate-specific antigen screening and mortality from prostate cancer
@ast
Prostate-specific antigen screening and mortality from prostate cancer
@en
P2093
P2860
P1476
Prostate-specific antigen screening and mortality from prostate cancer
@en
P2093
Frances Merlino
George G Rhoads
Homer Wilcox
Jeffrey L Carson
Stephen W Marcella
P2860
P2888
P304
P356
10.1007/S11606-007-0479-7
P577
2008-01-03T00:00:00Z